These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

377 related items for PubMed ID: 26075455

  • 1. Corneal and Tear Film Changes After Botulinum Toxin-A in Blepharospasm or Hemifacial Spasm.
    Gunes A, Demirci S, Koyuncuoglu HR, Tok L, Tok O.
    Cornea; 2015 Aug; 34(8):906-10. PubMed ID: 26075455
    [Abstract] [Full Text] [Related]

  • 2. Tear meniscus, corneal topographic and aberrometric changes after botulinum toxin-a injection in patients with blepharospasm and hemifacial spasm.
    Bayraktar Bilen N, Bilen Ş, Topçu Yılmaz P, Evren Kemer Ö.
    Int Ophthalmol; 2022 Aug; 42(8):2625-2632. PubMed ID: 35355169
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Tear production and drainage after botulinum toxin A injection in patients with essential blepharospasm.
    Park DI, Shin HM, Lee SY, Lew H.
    Acta Ophthalmol; 2013 Mar; 91(2):e108-12. PubMed ID: 23425111
    [Abstract] [Full Text] [Related]

  • 8. Ocular surface status in patients with hemifacial spasm under long-lasting treatment with botulinum A toxin: A comparative fellow eye study.
    Pellegrini M, Schiavi C, Taroni L, Sebastiani S, Bernabei F, Roda M, Moscardelli F, Giannaccare G.
    Indian J Ophthalmol; 2019 Sep; 67(9):1405-1409. PubMed ID: 31436182
    [Abstract] [Full Text] [Related]

  • 9. Does blepharospasm effect biometric parameters and intraocular lens power calculations?
    Basol I, Ilhan HD.
    Int Ophthalmol; 2024 Aug 29; 44(1):358. PubMed ID: 39198275
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Comparison of two different formulations of botulinum toxin A for the treatment of blepharospasm and hemifacial spasm.
    Wu CJ, Shen JH, Chen Y, Lian YJ.
    Turk Neurosurg; 2011 Aug 29; 21(4):625-9. PubMed ID: 22194126
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Increase lipid tear thickness after botulinum neurotoxin A injection in patients with blepharospasm and hemifacial spasm.
    Ho RW, Fang PC, Chao TL, Chien CC, Kuo MT.
    Sci Rep; 2018 May 30; 8(1):8367. PubMed ID: 29849166
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Use of Alleviating Maneuvers for Periocular Facial Dystonias.
    Kilduff CL, Casswell EJ, Salam T, Hersh D, Ortiz-Perez S, Ezra D.
    JAMA Ophthalmol; 2016 Nov 01; 134(11):1247-1252. PubMed ID: 27606483
    [Abstract] [Full Text] [Related]

  • 18. The role of the injection botulinum toxin A in cases of blepharospasm syndrome, hemifacial spasm and Meige's syndrome.
    Bastola P, Chaudhary M, Agrawal JP, Shah DN.
    Kathmandu Univ Med J (KUMJ); 2010 Nov 01; 8(31):305-10. PubMed ID: 22610735
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.